ChemicalBook Product Catalog Pharmaceutical intermediates Heterocyclic compound Pyridine compound Cyanopyridine 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester

3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester

3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester Basic information
Product Name:3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester
Synonyms:3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester;Ethyl 3-(2-((4-cyanophenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido;Dabigatran Intermediate 3;ethyl 3-[[2-[(4-cyanoanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate;Dabigatran Etexilate Mesylate impurity I;ethyl 3-[[2-[(4-cyanoanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate (Dabigatran etexilate;-1H-benzo[d]imidazole-5-carboxamido);-1-methyl-N-(pyridin-2-yl)
CAS:211915-84-3
MF:C27H26N6O3
MW:482.53
EINECS:1592732-453-0
Product Categories:Intermediate of Dabigatran;pyridine;benzimidazole;Dabigatran intermediate;nitrile
Mol File:211915-84-3.mol
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester Structure
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester Chemical Properties
Melting point 149-151°C
Boiling point 756.4±60.0 °C(Predicted)
density 1.25±0.1 g/cm3(Predicted)
storage temp. Keep in dark place,Inert atmosphere,Room temperature
solubility DMSO (Slightly, Sonicated), Methanol (Very Slightly, Sonicated)
pka4.21±0.10(Predicted)
form Solid
color White to Pale Beige
InChIKeyOZBOESGNDSVMDK-UHFFFAOYSA-N
SMILESC(OCC)(=O)CCN(C(C1=CC=C2N(C)C(CNC3=CC=C(C#N)C=C3)=NC2=C1)=O)C1=NC=CC=C1
Safety Information
MSDS Information
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester Usage And Synthesis
Chemical PropertiesWhite Solid
UsesNonpeptide thrombin inhibitor intermediate.
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester Preparation Products And Raw materials
Preparation ProductsDabigatran Impurity 9-->Dabigatran iMpurity L-->Dabigatran Impurity 8
4-methoxy-N-methyl-3-nitrobenzamide N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride HEXYL CHLOROFORMATE 3-(S)-(+)-(1-Carbamoyl-1,1-diphenylmethyl)pyrroloidine-L-(+)-tartarate 3-[(3-AMINO-4-METHYLAMINO-BENZOYL)-PYRIDIN-2-YL-AMINO]-PROPIONIC ACID ETHYL ESTER ETHYL N-[4-(METHYLAMINO)-3-NITROBENZOYL]-N-PYRIDIN-2-YL-SS-ALANINATE Dabigatran Etexilate iMpurity 4-Aminobenzamidine dihydrochloride 5-(2-Bromoethyl)-2,3-dihydrobenzofuran Chloroacetic anhydride N-(4-CYANO-PHENYL)-GLYCINE Dabigatran Dabigatran etexilate Dabigatran ethyl AcOH Salt Benzonitrile N-[2]PYRIDYL-B-ALANIN-ETHYL ESTER N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]arbonyl]-N-2-pyridinyl-beta-alanine ethyl ester 4-methylbenzenesulfonate Dabigatran Etexilate Mesylate
Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.